Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 2/20 | 0.64 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.64 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.64 |
| ▸ | CA1 | P00915 | 2/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.52 |
| ▸ | SIRT5 | Q9NXA8 | 1/20 | 0.50 |
| ▸ | NPY1R | P25929 | 6/20 | 0.48 |
| ▸ | NPY5R | Q15761 | 3/20 | 0.48 |
| ▸ | F2 | P00734 | 1/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | GLA | P06280 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 1/20 | 0.45 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | APEX1 | P27695 | 1/20 | 0.45 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | FURIN | P09958 | 5/20 | 0.43 |
| ▸ | PCSK6 | P29122 | 1/20 | 0.43 |
| ▸ | SLC6A5 | Q9Y345 | 1/20 | 0.42 |
| ▸ | NPY4R | P50391 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13337947 | 1.00 | CHRM2 (0.64) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL29393341 | 0.86 | SIRT5 (0.64) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL14117893 | 0.85 | CHRM2 (0.69) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL16748402 | 0.83 | CHRM2 (0.68) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL29521677 | 0.83 | CHRM2 (0.68) | CHRM2CHRM4CHRM1CA1CA2 | |
| Water SCHEMBL30600465 | 0.82 | CHRM2 (0.66) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL22493159 | 0.81 | BMP1 (0.47) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL13698293 | 0.80 | SIRT6 (0.55) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL30080701 | 0.79 | CHRM2 (0.58) | CHRM2CHRM4CHRM1CA1CA2 | |
| SCHEMBL29595648 | 0.79 | FURIN (0.56) | CHRM2CHRM4CHRM1CA1CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12626189-B2 | Predicting a diagnostic test result from patient laboratory testing history | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2026-05-12 | — | — | US | disclosed |
| US-20260083365-A1 | METHOD AND SYSTEM FOR DETECTING A BIOANALYTE IN THE BLOOD | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2026-03-26 | — | — | US | disclosed |
| US-20250307550-A1 | TEXT AUGMENTATION USING DATASET RECONSTRUCTION | INTERNATIONAL BUSINESS MACHINES CORPORATION | 2025-10-02 | — | — | US | disclosed |
| WO-2025202415-A1 | DHODH INHIBITORS FOR USE IN THE CHRONOPHARMACOLIGICAL TREATMENT AND PREVENTION OF OBESITY AND OBESITY-RELATED METABOLIC DISORDERS | Institut National de la Santé et de la Recherche Médicale (FR) | 2025-10-02 | — | — | WO | disclosed |
| US-12306174-B2 | Diagnosis of cancer | OWLSTONE MEDICAL LIMITED (GB) | 2025-05-20 | — | — | US | disclosed |
| CN-117980830-B | Reference image grouping in overlay metrology | 科磊股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| EP-4430203-A1 | ASSAY | Owlstone Medical Limited (GB) | 2024-09-18 | — | — | EP | disclosed |
| US-20240301472-A1 | NUCLEIC ACID DETECTION METHOD, COMPOUND AND FLUORESCENT PROBE | WAKAYAMA UNIVERSITY (JP) | 2024-09-12 | — | — | US | disclosed |
| CN-118574939-A | Measurement | 奥斯通医疗有限公司 | 2024-08-30 | — | — | CN | disclosed |
| US-20240263188-A1 | APPLICATION OF BFNE GENE IN TOMATO PLANT ARCHITECTURE IMPROVEMENT AND BIOLOGICAL YIELD INCREASE | Institute of Horticultural Crops, Xinjiang Academy of Agricultural Sciences (CN) | 2024-08-08 | — | — | US | disclosed |
| WO-2023234865-A1 | A COMMUNICATION SERVER, A METHOD, A USER DEVICE, AND A SYSTEM | GRABTAXI HOLDINGS PTE. LTD. (SG) | 2023-12-07 | — | — | WO | disclosed |
| EP-4261209-A1 | NUCLEIC ACID DETECTION METHOD, COMPOUND AND FLUORESCENT PROBE | Wakayama University (JP) | 2023-10-18 | — | — | EP | disclosed |
| WO-2023150196-A1 | REFERENCE IMAGE GROUPING IN OVERLAY METROLOGY | KLA CORPORATION (US) | 2023-08-10 | — | — | WO | disclosed |
| WO-2023084219-A1 | ASSAY | OWLSTONE MEDICAL LIMITED (GB) | 2023-05-19 | — | — | WO | disclosed |
| WO-2023086651-A1 | PREDICTING A DIAGNOSTIC TEST RESULT FROM PATIENT LABORATORY TESTING HISTORY | LABORATORY CORPORATION OF AMERICA HOLDINGS (US) | 2023-05-19 | — | — | WO | disclosed |
| US-20230145258-A1 | Predicting a Diagnostic Test Result From Patient Laboratory Testing History | LABORATORY CORPORATION OF AMERICA HOLDINGS | 2023-05-11 | — | — | US | disclosed |
| WO-2023065966-A1 | APPLICATION OF BFNE GENE IN TOMATO PLANT TYPE IMPROVEMENT AND BIOLOGICAL YIELD INCREASE | 新疆农业科学院园艺作物研究所 | 2023-04-27 | — | — | WO | disclosed |
| WO-2022124148-A1 | NUCLEIC ACID DETECTION METHOD, COMPOUND AND FLUORESCENT PROBE | 国立大学法人 和歌山大学 | 2022-06-16 | — | — | WO | disclosed |
| WO-2022085007-A1 | DEVICE, SYSTEMS AND METHODS FOR DETECTION OF NUCLEIC ACID MOLECULES OF INTEREST | TECHNION RESEARCH & DEVELOPMENT FOUNDATION LTD. (IL) | 2022-04-28 | — | — | WO | disclosed |
| CN-114369147-A | Application of BFNE gene in tomato plant type improvement and biological yield improvement | 新疆农业科学院园艺作物研究所 | 2022-04-19 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240301472-A1 | NUCLEIC ACID DETECTION METHOD, COMPOUND AND FLUORESCENT PROBE | POLRMT, DNA2, ADAR | CHRM2 4850/4885CHRM4 4653/4885CHRM1 4822/4885 |
| US-20260083365-A1 | METHOD AND SYSTEM FOR DETECTING A BIOANALYTE IN THE BLOOD | STAT3, CD47, FGF23 | CHRM2 3461/4885CHRM4 3118/4885CHRM1 3886/4885 |
| US-12626189-B2 | Predicting a diagnostic test result from patient laboratory testing history | KLKB1, LDHB, BRCA1 | CHRM2 4800/4885CHRM4 4848/4885CHRM1 4854/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.